Note: Ingredients listed on restricted chemical lists
EC/CAS
8001-54-5
Name of the chemical
Benzalkonium chloride; Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
Concentration
100%
General Information
Revision date
2022-06-27
Product name
PLACEBO NASAL SPRAY
Product Synonyms
PLACEBO FOR FLUTICASONE FUROATE NASAL SPRAY, SUSPENSION * PLACEBO NASAL
CAS No.
8001-54-5
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
None
Hazard Codes
Hazard statements (CLP)
H412
Hazard statements
Code
Statements
H412
Harmful to aquatic life with long lasting effects
Section 2
EU Classification
Regulation 26/12/2008-27092 as amended Classification in accordance with Regulation 28848 regarding the Classification, Packaging and Labeling of Substances and Preparations 12/11/2013.
Physical hazards
Not classified.
Health hazards
Not classified.
Environmental hazards
Hazardous to the aquatic environment, Category 3
Hazard pictograms
None.
Signal word
None.
Hazard statements
H412 Harmful to aquatic life with long lasting effects.
Prevention
P273 Avoid release to the environment.
Response
Not available.
Storage
Not available.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Additional information
5 % of the mixture consists of component(s) of unknown acute oral toxicity. 5 % of the mixture consists of component(s) of unknown acute dermal toxicity. 6,5 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 5 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 5 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
2.3 Other hazards
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
